In particular, the BDNF polymorphism resulting in a Val66Met substitution, which reduces the activity-dependent neuronal secretion of BDNF (Egan et al., 2003), accounts for up to 30% of the variability in cognitive decline in AD patients (Lim et al., 2013, 2015). This evidence concerns the gene BDNF and Mental deterioration.